公司为寻求全面健康解决方案的用户提供健康相关服务，包括早期疾病筛查相关推广及咨询、健康检查 及咨询、医疗预约服务以及保健品销售。作为公司服务的重要组成部分，公司亦赋能行业参与者以数字 营销的形式策划优质科普内容，并推广健康相关公共举措。为了资助用户的健康支出，并满足其保障需 求，公司亦通过公司的互联网保险平台保险相关服务，为用户提供方便地获取各种健康保险产品的机 会。公司的综合平台提供健康服务和保险资金资源，能够满足用户的整体健康需求。 按发售价为每股发售股份22.68港元计算(假设超额配股权未获行使)，全球发售所得款项净额将约为 5.134亿港元。集团拟将全球发售所得款项净额用于以下用途：约40.0%将用于提升集团的品牌知名度、 提高用户参与度及加强与业务合作伙伴的合作;约20.0%将用于医学研究和真实世界研究;约20.0%将用于 提升集团在AI及大数据领域的技术能力，以便更广泛应用于集团的产品及服务;约10.0%将用于拓展至更 多地区及海外市场;及约10.0%用作营运资金及其他一般公司用途。 智通财经APP讯，轻松健康(02661)于2025年12月15日至12月18日招股，该公司拟全球发售2654万股， ...

格隆汇12月15日丨轻松健康(02661.HK)发布公告，公司拟全球发售2654万股股份，中国香港发售股份 265.4万股，国际发售股份2388.6万股(以上可予重新分配及视乎超额配股权行使与否而定)；2025年12月 15日至12月18日招股；发售价将为每股发售股份22.68港元，股份将以每手200股股份买卖，中金公司及 招商证券国际为联席保荐人；预期股份将于2025年12月23日开始在联交所买卖。 按发售价为每股发售股份22.68港元计算(假设超额配股权未获行使)，全球发售所得款项净额将约为 5.134亿港元。集团拟将全球发售所得款项净额用于以下用途：约40.0%将用于提升集团的品牌知名度、 提高用户参与度及加强与业务合作伙伴的合作；约20.0%将用于医学研究和真实世界研究；约20.0%将 用于提升集团在AI及大数据领域的技术能力，以便更广泛应用于集团的产品及服务；约10.0%将用于拓 展至更多地区及海外市场；及约10.0%用作营运资金及其他一般公司用途。 集团于中国提供健康相关及保险相关解决方案。根据沙利文报告的资料，按2024年的收入计，集团于中 国数字综合健康服务及健康保险服务市场排名第10位。具体 ...

Core Viewpoint - The company, Easy Health Group, is pursuing an IPO in Hong Kong, revealing significant revenue growth but a substantial decline in net profit margin, warranting further investigation into the underlying causes [1] Business Model - Easy Health Group operates as a one-stop health service platform, focusing on digital comprehensive health services and health insurance solutions, ranking 10th in the domestic market for digital comprehensive health services and 7th in the digital health service market by 2024 [2] - The business model is built on two main pillars: digital comprehensive health services and digital insurance services, with a strong emphasis on digital marketing and medical research support for pharmaceutical companies [2] Financial Data Analysis - Revenue has shown significant growth, with figures of RMB 394 million in 2022, RMB 490 million in 2023 (up 24.5% year-on-year), and projected RMB 945 million in 2024 (up 92.9% year-on-year), indicating a robust growth trend [3][4] - The first half of 2025 has already surpassed the total revenue of 2023, reaching RMB 656 million, demonstrating continued positive momentum [3] Profitability Metrics - Adjusted net profit has declined from RMB 1.49 billion in 2022 to RMB 1.47 billion in 2023, and further down to RMB 840 million in 2024, representing a 43.4% decrease from 2022 [4][5] - The net profit margin has fluctuated, with a significant drop from 19.8% in 2023 to 1.0% in 2024, reflecting instability in profitability [6] Revenue Composition - The revenue composition has diversified, with digital comprehensive health services increasing from 15.2% in 2022 to 65.3% in 2024, while digital marketing services have seen rapid growth, from RMB 23 million in 2023 to RMB 468 million in 2024 [7][8] Financial Challenges - The company faces financial challenges with net liabilities of RMB 12.41 billion in 2022, slightly decreasing to RMB 11.31 billion by mid-2025, indicating a need for improved capital structure [9] Competitive Landscape - Easy Health Group ranks 10th in the domestic digital comprehensive health services and health insurance market, with the market being highly fragmented and competitive, as the top 15 platforms hold less than 10% of the total market share [10] Customer and Supplier Concentration - The company has a high customer concentration, with the top five clients contributing 75.4% of total revenue in 2022, which poses a risk of revenue volatility [11] - Supplier concentration is also notable, with the top five suppliers accounting for 42.0% of total procurement in 2022, indicating potential risks if relationships with key suppliers deteriorate [11] Management and Ownership Structure - The founder and CEO, Ms. Yang, controls over 30% of the voting rights through a wholly-owned company, supported by a management team with extensive experience in health services and insurance [12]